We recently released a list Jim Cramer Radar 8 Sharp. In this article, we will explore what Kremer points out when Concorra Corporation (NYSE:COR) opposes other stocks recently discussed by Jim Cramer.
In Wednesday's episode of "Crazy Money", Jim Cramer reviewed the latest developments that affected the drug distribution company and shed light on why he was cautious about the group. He noted that stocks of major drug distributors have retreated from their historical heights.
“For the most part, this is because some type of regulatory crackdown forces them to go bankrupt, or at least reduce their profitability a lot.”
Please read also Jim Cramer recently placed these 8 stocks under a microscope and Jim Cramer commented on these 6 natural gas players
Cramer last week mentioned the president's executive order to lower drug prices, which triggered a sell-off in the entire drug distribution sector. He explained that the order effectively requires pharmaceutical companies to provide U.S. government drug prices that match the lowest interest rates charged by other advanced economies. Cramer said the market’s fear is simple: If drugmakers are forced to lower prices for their government customers, drug distributors can see their profit margins shrink.
"The most important thing is: I don't want to stick my neck out for an industry regardless of how drug distributors perform, and both Democrats and Republicans seem to hate the industry right now. That seems to be the only thing they agree with, right, isn't it? There are so many potential winners in this market, and I say, why take the risk?"
In this article, we compiled a list of 8 stocks discussed by Jim Cramer in "Crazy Money" aired on May 14. We list these stocks in the order mentioned by Cramer. As of the fourth quarter of 2024, we also provided hedge fund sentiment for each stock, taken from Insider Monkey’s database of over 1,000 hedge funds.
Why are we interested in stocks that hedge funds to accumulate? The reason is simple: Our research shows that we can beat the market by mimicking the top stocks of the best hedge funds. Our strategy for quarterly newsletters selects 14 small and large stocks every quarter, returning 373.4% since May 2014, beating its benchmark by 218 percentage points (See more details here).
Number of hedge fund holders: 58
Cramer noted that when NYSE:COR “eliminates it out of the park,” its earnings report always seems to be in danger.
“These stocks, namely Cardinal Health, Cencora, and McKesson, are seemingly perpetual residents on the new high list. Over the long haul, they're some of the best performers out there, and they've done great this year, as is pretty much always the case. And yet, doesn't it always feel like the drug distributors are just one bad day away from falling apart… Cencora… knocked it out of the park when they reported last Wednesday… Posted a slight top line miss but Monster lost $4 in revenue (and 11% base).
Scan (NYSE:COR) distributes medicines and provides medical services in global markets. The company supports its providers through pharmacy operations, clinical trial assistance and key logistics solutions.
Overall, Cor Ranked fifth On the list of stocks recently discussed by Jim Cramer. Although we acknowledge the potential of COR as an investment, our belief is that AI stocks have greater hope to offer higher returns and do so in a shorter time frame. AI stocks have risen since the beginning of 2025, while popular AI stocks have lost about 25%. If you are looking for AI stocks that are more promising than COR but have less than 5 times the gains, check out our report Cheapest AI stocks.
Read the next article: Buy 20 Best AI Stocks Now and According to the billionaire, there are now 30 best stocks.
Disclosure: None. This article was originally published in Inside monkey.